Browse by Section 100 Item List

Highly Specialised Drugs Program (Public Hospital)

For Pharmaceutical Benefits Scheme (PBS) Highly Specialised Drugs prescribed through public hospitals, claiming and approval of authority prescriptions is administered by Services Australia. Highly Specialised Drugs prescribed in public hospitals are Authority Required items. Application for authorisation can be made by either:

  • posting an Authority Prescription form and other application form(s), where applicable to Services Australia
  • using the form upload facility in Health Professional Online Services (HPOS)
  • using the Online PBS Authorities system (see www.servicesaustralia.gov.au/HPOS)
  • using the Services Australia free-call service for PBS Complex Drugs Programs enquiries (1800 700 270) or
  • using the appropriate Streamlined code.

Prescribers must quote the provider number of the hospital when applying. Maximum quantities and repeats for Highly Specialised Drugs are listed in the PBS Schedule. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats.

Public hospital prescriptions for Highly Specialised Drugs can be dispensed by public hospital pharmacies and some of these prescriptions can be dispensed by a community pharmacy. A patient may be required to pay a contribution for each supply of a highly specialised drug at a similar rate to the PBS. Commonwealth subsidy is not available for hospital in-patients.

Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.

  • Legend
  • MPMedical Practitioner
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MP 12856P RAVULIZUMABravulizumab 1.1 g/11 mL injection, 11 mL vial 1 1 0
MP 12883C RAVULIZUMABravulizumab 1.1 g/11 mL injection, 11 mL vial 1 1 2
MP 13797E RAVULIZUMABravulizumab 1.1 g/11 mL injection, 11 mL vial 1 1 2
MP 13809T RAVULIZUMABravulizumab 1.1 g/11 mL injection, 11 mL vial 1 1 0
MP 12884D RAVULIZUMABravulizumab 300 mg/3 mL injection, 3 mL vial 1 1 2
MP 12898W RAVULIZUMABravulizumab 300 mg/3 mL injection, 3 mL vial 1 1 0
MP 13785M RAVULIZUMABravulizumab 300 mg/3 mL injection, 3 mL vial 1 1 2
MP 13808R RAVULIZUMABravulizumab 300 mg/3 mL injection, 3 mL vial 1 1 0
MPNP 12786Y RIBAVIRINribavirin 200 mg tablet, 100 2 200 2
MPNP 9541E RIFABUTINrifabutin 150 mg capsule, 30 4 120 5
MP 11001B RIOCIGUATriociguat 500 microgram tablet, 42 1 42 0
MP 11040C RIOCIGUATriociguat 500 microgram tablet, 42 1 42 0
MP 10976Q RIOCIGUATriociguat 1 mg tablet, 42 1 42 0
MP 11054T RIOCIGUATriociguat 1 mg tablet, 42 1 42 0
MP 10989J RIOCIGUATriociguat 1.5 mg tablet, 42 1 42 0
MP 11047K RIOCIGUATriociguat 1.5 mg tablet, 42 1 42 0
MP 10984D RIOCIGUATriociguat 2 mg tablet, 42 1 42 0
MP 11038Y RIOCIGUATriociguat 2 mg tablet, 42 1 42 0
MP 11002C RIOCIGUATriociguat 2.5 mg tablet, 42 1 42 0
MP 11057Y RIOCIGUATriociguat 2.5 mg tablet, 42 1 42 0
MP 12606L RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 1 1 5
MP 12614X RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 1 1 0
MP 12943F RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 1 1 0
MP 13631K RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 3 3 5
MP 13633M RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 3 3 5
MP 13654P RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 3 3 7
MP 13655Q RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 1 1 0
MP 13656R RISDIPLAMrisdiplam 750 microgram/mL powder for oral liquid, 80 mL 3 3 5
MP 13088W RITUXIMABrituximab 100 mg/10 mL injection, 10 mL vial 6 6 0
MP 13082M RITUXIMABrituximab 100 mg/10 mL injection, 2 x 10 mL vials 3 6 0
MP 13101M RITUXIMABrituximab 500 mg/50 mL injection, 50 mL vial 2 2 1
MP 9696H ROMIPLOSTIMromiplostim 250 microgram injection, 1 vial 1 1 5
MP 9698K ROMIPLOSTIMromiplostim 500 microgram injection, 1 vial 1 1 5
MP 13238R RUXOLITINIBruxolitinib 5 mg tablet, 56 1 56 5
MP 13243B RUXOLITINIBruxolitinib 5 mg tablet, 56 1 56 0
MP 13232K RUXOLITINIBruxolitinib 10 mg tablet, 56 1 56 0
MP 13245D RUXOLITINIBruxolitinib 10 mg tablet, 56 1 56 5